13C-Methacetin Breath Test for the Prediction of Outcome in ALF (ALF-MBT)

Clinical Trial ID NCT02786836

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02786836

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Early indicators of prognosis in fulminant hepatic failure.	Gastroenterology	1989	7.43
2	Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.	Aliment Pharmacol Ther	2006	2.00
3	Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.	J Hepatol	2000	1.66
4	A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.	J Viral Hepat	2008	0.92
5	Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.	World J Gastroenterol	2009	0.90
6	13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry.	Aliment Pharmacol Ther	2007	0.87
7	Systematic review: prognostic tests of paracetamol-induced acute liver failure.	Aliment Pharmacol Ther	2010	0.86
8	13C-breath tests in the study of microsomal liver function.	Eur Rev Med Pharmacol Sci	2004	0.85
9	Analgesic potency and acute toxicity of substituted anilides and benzamides.	Toxicol Appl Pharmacol	1971	0.78
10	Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.	J Hepatol	2015	0.75
11	The Natural History of Severe Acute Liver Injury.	Am J Gastroenterol	2017	0.75